Advanced Therapeutics

Papers
(The H4-Index of Advanced Therapeutics is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Advances in Antimicrobial Organic and Inorganic Nanocompounds in Biomedicine82
From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier69
Magnetic Fluid Hyperthermia Based on Magnetic Nanoparticles: Physical Characteristics, Historical Perspective, Clinical Trials, Technological Challenges, and Recent Advances68
Clinical Translation of Nanomedicine and Biomaterials for Cancer Immunotherapy: Progress and Perspectives63
Polymeric Nanoparticles for Nasal Drug Delivery to the Brain: Relevance to Alzheimer's Disease61
Nanoplatforms for mRNA Therapeutics61
Engineered Microneedle Patches for Controlled Release of Active Compounds: Recent Advances in Release Profile Tuning52
Glucose Oxidase‐Related Cancer Therapies43
Project IDentif.AI: Harnessing Artificial Intelligence to Rapidly Optimize Combination Therapy Development for Infectious Disease Intervention42
Engineering Strategies for Immunomodulatory Cytokine Therapies: Challenges and Clinical Progress42
A Bioactive Living Hydrogel: Photosynthetic Bacteria Mediated Hypoxia Elimination and Bacteria‐Killing to Promote Infected Wound Healing42
Emerging Technologies for Local Cancer Treatment40
Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis37
Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches34
Biomedical Applications of Polymeric Microneedles for Transdermal Therapeutic Delivery and Diagnosis: Current Status and Future Perspectives33
Alkaline Phosphatase: A Reliable Endogenous Partner for Drug Delivery and Diagnostics33
Mn3O4 Nanozyme for Inflammatory Bowel Disease Therapy32
A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy32
Clinical Translation of Self‐Assembled Cancer Nanomedicines32
SQ3370 Activates Cytotoxic Drug via Click Chemistry at Tumor and Elicits Sustained Responses in Injected and Non‐Injected Lesions29
Stimuli‐Responsive Biomaterials for Vaccines and Immunotherapeutic Applications27
Engineered Ovalbumin Nanoparticles for Cancer Immunotherapy26
Applying CRISPR/Cas13 to Construct Exosomal PD‐L1 Ultrasensitive Biosensors for Dynamic Monitoring of Tumor Progression in Immunotherapy26
Local Depletion of Immune Checkpoint Ligand CTLA4 Expressing Cells in Tumor Beds Enhances Antitumor Host Immunity26
Preventive Efficacy of a Tenofovir Alafenamide Fumarate Nanofluidic Implant in SHIV‐Challenged Nonhuman Primates26
One‐Pot Synthesis of pH‐Responsive Eudragit‐Mesoporous Silica Nanocomposites Enable Colonic Delivery of Glucocorticoids for the Treatment of Inflammatory Bowel Disease25
Near‐Infrared Fluorescence/Photoacoustic Agent with an Intensifying Optical Performance for Imaging‐Guided Effective Photothermal Therapy25
0.036195993423462